Health TrialsbyHealthPanel

A Personalized Video-based Exercise Program for Fall Prevention in Frail and Pre-frail Older Adult

ConditionsFall InjuryFrailtyOld Age; AtrophyAge-Related AtrophyAge-Related Sarcopenia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age70+
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

About this trial

This is a randomized interventional clinical trial, whereby 100 participants will be randomized to either follow the SAFE exercise program (experimental group) or not (control group). At the end of the intervention, the experimental group will be encouraged to continue doing the exercises, and the control group will have the opportunity to participate in the SAFE exercises. 12 weeks post-intervention, the investigators will follow up with participants by telephone to follow up whether they are still following the SAFE program or not.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Considered Frail or Pre frail according to Fried's criteria

Disqualifiers

Smoked within 6 months prior to study enrollment,

dementia diagnosos,

Abused drugs, medication or alcohol within up to 30 days prior to the start of the study.

drug or alcohol-addiction,

Trial design

Design model

Parallel

Treatments tested in this trial

  • SAFE program (exercise intervention)

    Other intervention

    Participants will be asked to carry out the SAFE program with the help of a caregiver. Our healthcare professionals will visit them during the first week to explain to them and their caregivers how to perform the exercises correctly while using our website. All exercises will be performed using video capsules available on our website (https://safe-seniors.com/fr). The exercises are divided into 4 levels of difficulty: level 1 (light); level 2 (moderate); level 3 (moderate to vigorous); and level 4 (vigorous). Each level lasts 25 to 30 minutes and includes 5 exercise categories split into 5 videos: warm-up, strength, balance, flexibility, and endurance. The exercise intervention will include 3 sessions per week over 12 weeks.

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: SAFE programExperimental treatment 1 intervention
Group B: Control groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Objective 1

Number of participants that displayed changes on their functional testing (SPPB) in comparison with their baseline and the control group after having participated in the SAFE program, following the 12 week intervention.

Time frame
12 weeks
2

Objective 2

Number of participants that displayed changes on their cognitive (STROOP) in comparison with their baseline and the control group after having participated in the SAFE program, following the 12 week intervention.

Time frame
12 weeks

Secondary outcomes

1

Objective 4

Number of participants that displayed changes on their FES-I test in comparison with their baseline and the control group after having participated in the SAFE program, following the 12 week intervention.

Time frame
12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead sponsor

Source ClinicalTrials.gov
Apply now